Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efstathios Kastritis

Showing results (1-10 of 512) with videos related to

Pageof 52
Sort By:
Blood|October 16, 2025
BCMA: BeCoMing a new hope for AL amyloidosisEfstathios Kastritis
Leukemia|March 7, 2024
There's life in the old dog yet: immunochemotherapy in Waldenström's macroglobulinemiaEfstathios Kastritis, Christian Buske
Leukemia & Lymphoma|January 19, 2008
High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?Meletios Dimopoulos, Efstathios Kastritis
Leukemia & Lymphoma|December 11, 2007
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomideEfstathios Kastritis, Meletios Dimopoulos
Cancer|July 13, 2025
Are transplant strategies in relapsed myeloma relevant in the cellular treatment era?Despina Fotiou, Efstathios Kastritis
Therapeutic Advances in Hematology|December 30, 2024
Optimal use of BTK inhibitors in Waldenström's macroglobulinemia: combination or single drug approach?Eirini Solia, Efstathios Kastritis
Expert Opinion on Pharmacotherapy|February 21, 2007
The evolving role of lenalidomide in the treatment of hematologic malignanciesEfstathios Kastritis, Meletios A Dimopoulos
Nature Clinical Practice. Oncology|September 10, 2008
Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myelomaMeletios A Dimopoulos, Efstathios Kastritis
Blood|July 30, 2011
Bortezomib for AL amyloidosis: moving forwardMeletios A Dimopoulos, Efstathios Kastritis
Blood|August 26, 2017
Daratumumab combinations: what can we learn?Efstathios Kastritis, Meletios A Dimopoulos
Pageof 52

Showing results (1-10 of 512) with videos related to

Sort By:
Pageof 52
Blood|October 16, 2025
BCMA: BeCoMing a new hope for AL amyloidosisEfstathios Kastritis
Leukemia|March 7, 2024
There's life in the old dog yet: immunochemotherapy in Waldenström's macroglobulinemiaEfstathios Kastritis, Christian Buske
Leukemia & Lymphoma|January 19, 2008
High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?Meletios Dimopoulos, Efstathios Kastritis
Leukemia & Lymphoma|December 11, 2007
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomideEfstathios Kastritis, Meletios Dimopoulos
Cancer|July 13, 2025
Are transplant strategies in relapsed myeloma relevant in the cellular treatment era?Despina Fotiou, Efstathios Kastritis
Therapeutic Advances in Hematology|December 30, 2024
Optimal use of BTK inhibitors in Waldenström's macroglobulinemia: combination or single drug approach?Eirini Solia, Efstathios Kastritis
Expert Opinion on Pharmacotherapy|February 21, 2007
The evolving role of lenalidomide in the treatment of hematologic malignanciesEfstathios Kastritis, Meletios A Dimopoulos
Nature Clinical Practice. Oncology|September 10, 2008
Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myelomaMeletios A Dimopoulos, Efstathios Kastritis
Blood|July 30, 2011
Bortezomib for AL amyloidosis: moving forwardMeletios A Dimopoulos, Efstathios Kastritis
Blood|August 26, 2017
Daratumumab combinations: what can we learn?Efstathios Kastritis, Meletios A Dimopoulos
Pageof 52